The SARS-CoV-2 Rapid Antibody Test is intended for the use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection. This rapid lateral flow test qualitatively detects IgM and IgG specific to SARS-CoV-2 in serum, plasma and whole blood.
Results in 10 – 15 minutes.
GOVERNMENT APPROVED TESTERS
UKAS STAGES 1 APPROVED
